Norges Bank acquired a new position in shares of Novocure Ltd (NASDAQ:NVCR) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The
Bionano Genomics (NASDAQ:BNGO) initiated with an Outperform rating and a $1.50 (443% upside) price target at Oppenheimer. Shares up 19% premarket.NovoCure (NASDAQ:NVCR) initiated with an Overweight
Guggenheim Capital LLC acquired a new stake in Novocure Ltd (NASDAQ:NVCR) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. T
Nuveen Asset Management LLC reduced its position in Novocure Ltd (NASDAQ:NVCR) by 1.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commi
In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on NovoCure (NVCR), with a price target of $82.00. The company's
In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on NovoCure (NVCR – Research Report),
Novocure Ltd (NASDAQ:NVCR)’s stock price dropped 6.6% on Tuesday after Wells Fargo & Co lowered their price target on the stock from $90.00 to $82.00. Wells Fargo & Co currently has an overweight ra

Is NovoCure (NASDAQ:NVCR) A Risky Investment?

07:07pm, Tuesday, 07'th Apr 2020
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Medical Services Outlook Bright Amid Coronavirus Crisis
Despite the coronavirus-led worldwide sales disruption, medical services is one of the few sectors witnessing industry-wide growth right now.
Brokerages expect that Novocure Ltd (NASDAQ:NVCR) will report earnings of $0.07 per share for the current quarter, according to Zacks. Four analysts have provided estimates for Novocure’s earnings,
Geode Capital Management LLC raised its position in Novocure Ltd (NASDAQ:NVCR) by 12.8% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 680,315 shares of the medic

Novocure (NASDAQ:NVCR) Trading Up 9.1%

06:38am, Tuesday, 07'th Apr 2020
Novocure Ltd (NASDAQ:NVCR)’s share price was up 9.1% during trading on Monday . The stock traded as high as $69.63 and last traded at $69.10, approximately 781,349 shares changed hands during mid-da
Bank of New York Mellon Corp boosted its stake in shares of Novocure Ltd (NASDAQ:NVCR) by 0.5% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3
Alliancebernstein L.P. increased its holdings in shares of Novocure Ltd (NASDAQ:NVCR) by 23.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchang
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE